Primera cohorte comunitaria post-COVID-19 en el norte del Perú: protocolo para la evaluación bimodal de las secuelas pulmonares y psicológicas. Estudio SUYAY TUMPIS.
DOI:
https://doi.org/10.35434/rcmhnaaa.2026.191.3159Palabras clave:
COVID-19, secuelas post-COVID, cohorte ambidireccional, función pulmonar, salud mental, PerúResumen
La pandemia por SARS-CoV-2 generó una carga significativa de secuelas post-COVID-19, que incluyen deterioro de la función pulmonar y morbilidad psicológica. En el Perú, la evidencia a nivel comunitario sobre estas secuelas es escasa, particularmente en entornos rurales. SUYAY TUMPIS es un estudio observacional de cohorte abierta ambidireccional diseñado para determinar las secuelas pulmonares y psicológicas en supervivientes de COVID-19 procedentes de comunidades urbanas y rurales de la región Tumbes, norte del Perú. Se enrolará a un total de 270 adultos (edad ≥18 años) con antecedente de COVID-19 entre 2020 y 2021, procedentes de Puerto Pizarro (rural) y el AAHH Las Flores (periurbano), junto con 30 controles negativos para COVID-19. Las evaluaciones se realizarán en los meses 0, 6 (condicional) y 12. La función pulmonar se evaluará mediante espirometría portátil (Datospir Aira-T: FVC, FEV1, FEV1/FVC, PEF) y tomografía computada de tórax sin contraste (SIEMENS SOMATOM GO, 16 cortes) al inicio del estudio. La ansiedad se tamizará mediante el cuestionario de Trastorno de Ansiedad Generalizada-7 (GAD-7), aplicado durante visitas domiciliarias en los meses 0 y 12. El análisis estadístico incluirá modelos lineales generalizados (familia Poisson), análisis de sobrevida (Kaplan-Meier, regresión de Cox) y ANOVA de medidas repetidas. SUYAY TUMPIS es la primera cohorte comunitaria post-COVID-19 en el norte del Perú que incorpora evaluación bimodal (pulmonar y psicológica). Sus resultados contribuirán a la planificación sanitaria regional basada en evidencia.
Descargas
Referencias
1. WHO Coronavirus (COVID-19) Dashboard [Internet]. World Health Organization; 2022 [cited 2022 Oct 4]. Available from: https://covid19.who.int
2. Deng SQ, Peng HJ. Characteristics of and public health responses to the Coronavirus Disease 2019 outbreak in China. J Clin Med. 2020;9(2):575. doi: 10.3390/jcm9020575
3. Salcedo-Matienzo J, Zavala-Flores E, Salazar-Gavino S, Eunofre-Hipolo B, Berrocal-Kasay A. Young adults hospitalized with COVID-19. Acta Med Peru. 2020;37(4):568–71. doi: 10.35663/amp.2020.374.1303
4. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15. doi: 10.1038/s41591-021-01283-z
5. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8
6. Carfi A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5. doi: 10.1001/jama.2020.12603
7. Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 2020;26:e928996. doi: 10.12659/MSM.928996
8. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217. doi: 10.1183/13993003.01217-2020
9. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750–2. doi: 10.1016/S2213-2600(20)30222-8
10. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295(3):715–21. doi: 10.1148/radiol.2020200370
11. Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19. Eur Respir J. 2021;57(4):2003481. doi: 10.1183/13993003.03481-2020
12. Yazji B, Jiang D, Ho D, Huang SH, Leipsic J, Cowan J. Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection. PLoS One. 2022;17(11):e0277624. doi: 10.1371/journal.pone.0277624
13. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832. doi: 10.1016/j.jns.2020.116832
14. Payus AO, Lin CLS, Noh MM, Jeffree MS, Ali RA. SARS-CoV-2 infection of the nervous system: a review of the literature on neurological involvement in novel coronavirus disease (COVID-19). Bosn J Basic Med Sci. 2020;20(3):283–92. doi: 10.17305/bjbms.2020.4860
15. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27. doi: 10.1016/S2215-0366(21)00084-5
16. Navarro ASH, Machado JA. Anosmia as an early symptom in patients with COVID-19. Rev Fac Med Hum. 2020;20(3):505–7. doi: 10.25176/RFMH.v20i3.3063
17. Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC. COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg. 2020;163(1):132–4. doi: 10.1177/0194599820922992
18. Coelho DH, Kons ZA, Costanzo RM, Reiter ER. Subjective changes in smell and taste during the COVID-19 pandemic: a national survey—preliminary results. Otolaryngol Head Neck Surg. 2020;163(2):302–6. doi: 10.1177/0194599820929957
19. Vogrig A, Gigli GL, Bna C, Morassi M. Stroke in patients with COVID-19: clinical and neuroimaging characteristics. Neurosci Lett. 2021;743:135564. doi: 10.1016/j.neulet.2020.135564
20. Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Manas R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601–5. doi: 10.1212/WNL.0000000000009619
21. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–8. doi: 10.1016/j.ijid.2020.03.062
22. Eliezer M, Hamel AL, Houdart E, Herman P, Housset J, Jourdaine C, et al. Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts. Neurology. 2020;95(23):e3145–52. doi: 10.1212/WNL.0000000000010806
23. McFadyen JD, Stevens H, Peter K. The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127(4):571–87. doi: 10.1161/CIRCRESAHA.120.317447
24. Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F. COVID-19 and cutaneous manifestations: a systematic review. J Eur Acad Dermatol Venereol. 2020;34(11):2505–10. doi: 10.1111/jdv.16778
25. Wu KK, Lee D, Sze AM, Ng VN, Cho VW, Cheng JP, et al. Posttraumatic stress, anxiety, and depression in COVID-19 survivors. Psychol Health Med. 2023;28(5):1349–59. doi: 10.1080/13548506.2022.2074072
26. Moreno-Perez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, et al. Post-acute COVID-19 syndrome: incidence and risk factors—a Mediterranean cohort study. J Infect. 2021;82(3):378–83. doi: 10.1016/j.jinf.2021.01.004
27. Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417
28. Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–58. doi: 10.1016/S0140-6736(21)01755-4
29. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32. doi: 10.1016/S0140-6736(20)32656-8
30. Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693
31. World Health Organization. Coronavirus [Internet]. Geneva: WHO; 2022 [cited 2022 Oct 4]. Available from: https://www.who.int/health-topics/coronavirus
32. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krlez̃a-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for randomized trials. Ann Intern Med. 2013;158(3):200–7. doi: 10.7326/0003-4819-158-3-201302050-00583
33. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. doi: 10.1001/archinte.166.10.1092
34. Micoulaud-Franchi JA, Lagarde S, Barkate G, Dufournet B, Besancon C, Trebuchon-Da Fonseca A, et al. Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7. Epilepsy Behav. 2016;57(Pt A):211–6. doi: 10.1016/j.yebeh.2016.02.015
35. Rathore JS, Jehi LE, Fan Y, Patel SI, Foldvary-Schaefer N, Ramirez MJ, et al. Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav. 2014;37:215–20. doi: 10.1016/j.yebeh.2014.06.030
36. Del Brutto VJ, Ortiz JG, Del Brutto OH, Mera RM, Zambrano M, Biller J. Total cerebral small vessel disease score and cognitive performance in community-dwelling older adults: results from the Atahualpa Project. Int J Geriatr Psychiatry. 2018;33(2):325–31. doi: 10.1002/gps.4737
37. Del Brutto OH, Mera RM, Zambrano M, Sedler MJ. Influence of frailty on cognitive decline: a population-based cohort study in rural Ecuador. J Am Med Dir Assoc. 2019;20(2):213–6. doi: 10.1016/j.jamda.2018.07.012
38. Cortes-Telles A, Lopez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, et al. Clinical predictors of lung function in patients recovering from mild COVID-19. Respir Med. 2022;198:106878. doi: 10.1186/s12890-022-02086-9
39. Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14–22. doi: 10.1111/ane.13266
40. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463
41. Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481. doi: 10.1183/13993003.03481-2020
42. Iversen KK, Ronit A, Kristiansen J, Benfield T. Lung function trajectories in mild COVID-19 with 2-year follow-up. J Infect Dis. 2024;229(4):1048–52. doi: 10.1093/infdis/jiae037
43. Centers for Disease Control and Prevention. COVID-19 and your health [Internet]. CDC; 2020 [cited 2022 Oct 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
44. Bjorsell T, Sundh J, Lange A, Ahlner F, Fagevik Olsen M, Bende M, et al. Risk factors for impaired respiratory function post COVID-19: a prospective cohort study of nonhospitalized and hospitalized patients. J Intern Med. 2023;293(6):765–77. doi: 10.1111/joim.13614
45. Acharya S, Kodali L. Post COVID-19 pulmonary complications in the outpatient setting: insights from a cross-sectional study in a rural academic hospital. Am J Emerg Med. 2023;69:191–4. doi: 10.1016/j.ajem.2023.03.031
46. Gorges AR, Tappenbeck NJ, Gaber R, Dirkmorfeld LM, Neugebauer S, Haefner MF, et al. Pulmonary function in non-hospitalized adults and children after mild COVID-19: a single-centre prospective cohort study. BMC Pulm Med. 2025;25(1):97. doi: 10.1186/s12890-025-04007-y
47. Daodu LP, Paudel A, Irani-Tehrani R, Majumdar A, Kayyali R. A retrospective observational study of pulmonary impairments in long COVID patients. Biomedicines. 2026;14(1):145. doi: 10.3390/biomedicines14010145
48. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9. doi: 10.1016/S0895-4356(96)00236-3
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Eva M. Rhor , Percy M. Vilchez Barreto, Franco E. León Jimenez , Martha P. Diaz Guevara, Grey Manriqu-Santur , Ricardo A. Puell-Calderon, Luz M. Moyano
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
